Skip to main content
. 2022 Feb 1;22:129. doi: 10.1186/s12885-022-09243-7

Table 5.

Statistical comparison of pharmacokinetic parameters at the first cycle (Indian population)

Parameter Geometric mean 90% CI
BCD-021 Reference bevacizumab
Cmax (μg/ml) 157.34 153.48 87.58% - 120.01%
AUC (μg·h/ml) 24519.49 25849.40 82.72% - 108.78%